Portfolio (Quarterly)
Guide ↗
SAMSARA BIOCAPITAL, LLC
· CIK 0001744967| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 6,897,652.0 | $303.8M | 31.35% | +1.3M | +22.9% | $44.05 | +9.3% |
| 2 | MLYS | MINERALYS THERAPEUTICS INC | Healthcare | 5,871,018.0 | $213.1M | 21.98% | -392K | -6.3% | $36.29 | -17.7% |
| 3 | KLRS | KALARIS THERAPEUTICS INC | Healthcare | 12,948,081.0 | $109.3M | 11.28% | +1.5M | +13.1% | $8.44 | -41.7% |
| 4 | SEPN | SEPTERNA INC | Healthcare | 3,149,128.0 | $87.8M | 9.06% | — | — | $27.88 | +1.7% |
| 5 | ALMS | ALUMIS INC | Healthcare | 5,756,984.0 | $56.2M | 5.80% | +956K | +19.9% | $9.76 | +125.6% |
| 6 | NGNE | NEUROGENE INC | Healthcare | 1,717,127.0 | $35.4M | 3.65% | — | — | $20.60 | +34.5% |
| 7 | IVA | INVENTIVA SA | Healthcare | 5,194,805.0 | $24.2M | 2.49% | NEW | — | $4.65 | +9.0% |
| 8 | GOSS | GOSSAMER BIO INC | Healthcare | 7,222,559.0 | $22.4M | 2.31% | +1.1M | +17.8% | $3.10 | -93.2% |
| 9 | — | UPSTREAM BIO INC | — | 736,047.0 | $20.0M | 2.06% | -226K | -23.5% | $27.15 | — |
| 10 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 2,500,000.0 | $16.1M | 1.67% | — | — | $6.46 | -36.2% |
| 11 | JBIO | JADE BIOSCIENCES INC | Healthcare | 968,798.0 | $14.9M | 1.54% | +438K | +82.4% | $15.43 | +43.9% |
| 12 | — | VTV THERAPEUTICS INC | — | 298,496.0 | $11.9M | 1.23% | -76K | -20.3% | $39.99 | — |
| 13 | RANI | RANI THERAPEUTICS HLDGS INC | Healthcare | 8,500,000.0 | $11.5M | 1.18% | NEW | — | $1.35 | -20.7% |
| 14 | PVLA | PALVELLA THERAPEUTICS INC NE | Healthcare | 104,817.0 | $11.0M | 1.13% | -105K | -50.0% | $104.67 | +8.9% |
| 15 | ABVX | ABIVAX SA | Healthcare | 75,442.0 | $10.2M | 1.05% | — | — | $134.86 | -9.5% |
| 16 | XFOR | X4 PHARMACEUTICALS INC | Healthcare | 1,960,000.0 | $7.8M | 0.81% | NEW | — | $4.00 | +1.0% |
| 17 | NKTX | NKARTA INC | Healthcare | 3,507,666.0 | $6.5M | 0.67% | -260K | -6.9% | $1.85 | +63.8% |
| 18 | ACLX | ARCELLX INC | Healthcare | 60,873.0 | $4.0M | 0.41% | -20K | -25.0% | $65.20 | +76.5% |
| 19 | — | SUTRO BIOPHARMA INC | — | 204,503.0 | $2.4M | 0.24% | NEW | — | $11.57 | — |
| 20 | CTNM | CONTINEUM THERAPEUTICS INC | Healthcare | 72,245.0 | $826K | 0.09% | -499K | -87.3% | $11.43 | +21.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%